Elevai Labs Inc (ELAB)

$2.60 +0.04 (1.56%)
Market Cap 6.63M
Revenue (ttm) 1.71M
Net Income (ttm) -4.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -251.46%
Debt to Equity Ratio 0.06
Volume 378,291
Avg Vol 1,507,805
Day's Range N/A - N/A
Shares Out 2.59M
Stochastic %K 44%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The compan...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 445 4886
Address:
120 Newport Center Drive, Suite 249, Newport Beach, United States
Ashyleary
Ashyleary Dec. 29 at 9:30 PM
$ELAB Where’s the guy that said he saw a bull flag at the close? He must be cross eyed. Lol 💩
1 · Reply
Trumpanzes
Trumpanzes Dec. 29 at 7:03 PM
$ELAB Everyday its -10%
0 · Reply
Taxed777
Taxed777 Dec. 29 at 6:59 PM
$ELAB Current stock price: about $1.4–$1.6 (recent trading range). Book Value Per Share (most recent reported): ~$11.41/share (from the Sept 30, 2025 quarter). What that implies Price-to-Book (P/B) Ratio: around 0.14 (i.e., price is ~14% of book value). StockAnalysis
0 · Reply
Taxed777
Taxed777 Dec. 29 at 6:56 PM
$ELAB AS9100 Typical effort: ⏱ 6–18 months of preparation 💰 $25K–$150K+ total cost (consulting + audits + internal labor) 📋 Heavy documentation and process discipline Many companies get AS9100 specifically to qualify to bid on aerospace/defense work
0 · Reply
Ashyleary
Ashyleary Dec. 29 at 6:49 PM
$ELAB Guess I was off by only a few days.
0 · Reply
Sam201
Sam201 Dec. 29 at 6:46 PM
$ELAB had to get another 2k now. 14k.
0 · Reply
cboca545
cboca545 Dec. 29 at 6:45 PM
$ELAB WTF!!
0 · Reply
Trumpanzes
Trumpanzes Dec. 29 at 6:44 PM
$ELAB Who is selling at these prices?
0 · Reply
RedShanksOfficial
RedShanksOfficial Dec. 29 at 5:37 PM
$ELAB Should see a 50-100% run off the lows very soon.
0 · Reply
Taxed777
Taxed777 Dec. 29 at 3:59 PM
$ELAB Added
0 · Reply
Latest News on ELAB
AGA Precision Systems LLC Achieves Globally Recognized AS9100 Certification for Aerospace, Defense, and Space Manufacturing, Exploring Future Humanoid Robotics Integration

Dec 22, 2025, 7:30 AM EST - 7 days ago

AGA Precision Systems LLC Achieves Globally Recognized AS9100 Certification for Aerospace, Defense, and Space Manufacturing, Exploring Future Humanoid Robotics Integration

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

Dec 17, 2025, 7:30 AM EST - 12 days ago

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

PMGC Holdings Inc. [Nasdaq: ELAB] Congratulates General Enterprise Ventures, Inc. [NYSE: CITR] on Its Uplisting to the NYSE American, Highlights Equity Stake

Dec 4, 2025, 10:57 AM EST - 25 days ago

PMGC Holdings Inc. [Nasdaq: ELAB] Congratulates General Enterprise Ventures, Inc. [NYSE: CITR] on Its Uplisting to the NYSE American, Highlights Equity Stake

PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update

Oct 20, 2025, 7:30 AM EDT - 2 months ago

PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update

Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases

Sep 4, 2025, 9:54 AM EDT - 4 months ago

Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

Aug 28, 2025, 10:30 AM EDT - 4 months ago

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

Univest Securities, LLC Announces Closing of $1.67 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Aug 25, 2025, 5:00 PM EDT - 4 months ago

Univest Securities, LLC Announces Closing of $1.67 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules

Aug 22, 2025, 1:48 PM EDT - 4 months ago

PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

Aug 13, 2025, 7:44 AM EDT - 4 months ago

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

Jul 30, 2025, 7:45 AM EDT - 5 months ago

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

Jul 18, 2025, 12:53 PM EDT - 5 months ago

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024

Jul 10, 2025, 8:30 AM EDT - 6 months ago

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

Jun 24, 2025, 8:30 AM EDT - 6 months ago

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Jun 18, 2025, 9:52 AM EDT - 6 months ago

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

Jun 17, 2025, 9:04 AM EDT - 6 months ago

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

Jun 16, 2025, 8:00 AM EDT - 7 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

Jun 9, 2025, 8:00 AM EDT - 7 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

May 22, 2025, 8:16 AM EDT - 7 months ago

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

May 14, 2025, 8:00 AM EDT - 8 months ago

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

TCRT

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Apr 29, 2025, 12:15 PM EDT - 8 months ago

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

Apr 28, 2025, 8:00 AM EDT - 8 months ago

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Apr 16, 2025, 8:00 AM EDT - 9 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

Apr 7, 2025, 5:30 PM EDT - 9 months ago

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

BON

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

Mar 28, 2025, 8:00 AM EDT - 9 months ago

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Mar 27, 2025, 8:00 AM EDT - 9 months ago

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Mar 24, 2025, 5:00 PM EDT - 10 months ago

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Mar 21, 2025, 2:41 PM EDT - 10 months ago

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

PMGC Holdings Announces Share Repurchases from Existing Shareholders

Mar 21, 2025, 8:00 AM EDT - 10 months ago

PMGC Holdings Announces Share Repurchases from Existing Shareholders

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

Feb 27, 2025, 8:00 AM EST - 10 months ago

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Feb 26, 2025, 8:30 AM EST - 10 months ago

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

Feb 4, 2025, 8:00 AM EST - 11 months ago

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Jan 31, 2025, 10:33 AM EST - 11 months ago

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Jan 28, 2025, 5:00 PM EST - 11 months ago

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Jan 27, 2025, 9:00 AM EST - 1 year ago

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

Jan 24, 2025, 8:00 AM EST - 1 year ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

Jan 16, 2025, 8:31 AM EST - 1 year ago

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

Jan 15, 2025, 9:30 AM EST - 1 year ago

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Jan 2, 2025, 3:55 PM EST - 1 year ago

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 PM EST - 1 year ago

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 AM EST - 1 year ago

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Dec 6, 2024, 7:30 AM EST - 1 year ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Nov 22, 2024, 6:23 PM EST - 1 year ago

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

Nov 22, 2024, 5:00 PM EST - 1 year ago

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

CORRECTION - Elevai Labs Inc.

Nov 14, 2024, 2:35 PM EST - 1 year ago

CORRECTION - Elevai Labs Inc.

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Nov 14, 2024, 9:08 AM EST - 1 year ago

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Nov 4, 2024, 5:45 PM EST - 1 year ago

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Oct 22, 2024, 9:54 AM EDT - 1 year ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Oct 21, 2024, 7:30 AM EDT - 1 year ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

Oct 4, 2024, 5:08 PM EDT - 1 year ago

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 3, 2024, 3:45 PM EDT - 1 year ago

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Ashyleary
Ashyleary Dec. 29 at 9:30 PM
$ELAB Where’s the guy that said he saw a bull flag at the close? He must be cross eyed. Lol 💩
1 · Reply
Trumpanzes
Trumpanzes Dec. 29 at 7:03 PM
$ELAB Everyday its -10%
0 · Reply
Taxed777
Taxed777 Dec. 29 at 6:59 PM
$ELAB Current stock price: about $1.4–$1.6 (recent trading range). Book Value Per Share (most recent reported): ~$11.41/share (from the Sept 30, 2025 quarter). What that implies Price-to-Book (P/B) Ratio: around 0.14 (i.e., price is ~14% of book value). StockAnalysis
0 · Reply
Taxed777
Taxed777 Dec. 29 at 6:56 PM
$ELAB AS9100 Typical effort: ⏱ 6–18 months of preparation 💰 $25K–$150K+ total cost (consulting + audits + internal labor) 📋 Heavy documentation and process discipline Many companies get AS9100 specifically to qualify to bid on aerospace/defense work
0 · Reply
Ashyleary
Ashyleary Dec. 29 at 6:49 PM
$ELAB Guess I was off by only a few days.
0 · Reply
Sam201
Sam201 Dec. 29 at 6:46 PM
$ELAB had to get another 2k now. 14k.
0 · Reply
cboca545
cboca545 Dec. 29 at 6:45 PM
$ELAB WTF!!
0 · Reply
Trumpanzes
Trumpanzes Dec. 29 at 6:44 PM
$ELAB Who is selling at these prices?
0 · Reply
RedShanksOfficial
RedShanksOfficial Dec. 29 at 5:37 PM
$ELAB Should see a 50-100% run off the lows very soon.
0 · Reply
Taxed777
Taxed777 Dec. 29 at 3:59 PM
$ELAB Added
0 · Reply
mymy2009
mymy2009 Dec. 29 at 11:44 AM
$ECDA 💥🤌🏻 $ELAB https://seekingalpha.com/pr/20348897-ecd-automotive-design-reports-early-traction-from-third-party-build-agreement
0 · Reply
StrategistBrady
StrategistBrady Dec. 29 at 7:11 AM
$ELAB watching again
0 · Reply
mymy2009
mymy2009 Dec. 28 at 1:13 PM
$ELAB internal purchasing process🔥⏳ 🤌🏻💥
0 · Reply
Miracles320
Miracles320 Dec. 27 at 1:13 AM
$ELAB i sold thinking it would sell monday morning instead sold after hours never done that before, pos now i have $236 left, i cant wait to die, anyways God bless you all
0 · Reply
Ashyleary
Ashyleary Dec. 27 at 1:07 AM
$ELAB Folks we have a bleeder 🩸
0 · Reply
BeauRegard
BeauRegard Dec. 26 at 11:25 PM
$ELAB haven't checked filing here yet - anyone know if they have been diluting? Or just shorts? If no dilution, approaching 1m market cap and I want to buy heavy
2 · Reply
Tony_37
Tony_37 Dec. 26 at 9:23 PM
$ELAB : lol green 🍀
0 · Reply
StMichaelTwits
StMichaelTwits Dec. 26 at 8:48 PM
$ELAB 👇😘Full hammer coming to the close.👉💪 Very crucial this opens up green Monday. If not, this is going below 1.50 as it was a fake full hammer from the shorts. If opens green, this is going over 1.70+ Monday.
0 · Reply
MyTummyHurts
MyTummyHurts Dec. 26 at 7:24 PM
$ELAB Can't imagine shorts wanting to hold this too much longer. Once they start covering this baby will heat up faster than a Junkies Spoon!
0 · Reply
StMichaelTwits
StMichaelTwits Dec. 26 at 7:15 PM
$ELAB Add to that..the fee rate is now high and not much available..👉💪 Recent Data Fee Available Updated 174.3 % 10,000 2025-12-26 12:55:52 174.3 % 10,000 2025-12-26 12:40:21 174.3 % 10,000 2025-12-26 12:24:50 174.3 % 10,000 2025-12-26 12:09:19
0 · Reply
StMichaelTwits
StMichaelTwits Dec. 26 at 7:14 PM
$ELAB Cute hammer is forming..if this can hold and opens green Monday. We have a reversal. Very close eye on this.
0 · Reply
MyTummyHurts
MyTummyHurts Dec. 26 at 6:56 PM
$ELAB
0 · Reply